Synopsis
Synopsis
0
USDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(2,4-dichloro Beta-(2,6-dichlorobenzyloxy)phenethyl) Imidazole
2. Fazol
3. Gyno Icaden
4. Gyno-travogen
5. Icaden
6. Isoconazole
7. R15454
8. Travogyn
1. 24168-96-5
2. Travogyn
3. Fazol
4. Isoconazole (nitrate)
5. Isoconazole Nitrate [jan]
6. Adestan G 100
7. R 15,454
8. 5as8p3n30x
9. 40036-10-0
10. 24168-96-5 (nitrate)
11. Travogen
12. Imidazole, 1-(2,4-dichloro-beta-((2,6-dichlorobenzyl)oxy)phenethyl)-, Mononitrate
13. Isoconazole Nitrate (jan)
14. 1-(2-(2,4-dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)-1h-imidazole Mononitrate
15. 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]-1h-imidazole Mononitrate
16. R-15454
17. Adestan G100
18. Gyno-travogen
19. 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]-1h-imidazole; Nitric Acid
20. 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole;nitric Acid
21. 1h-imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]-, Nitrate
22. 1-(2-((2,6-dichlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Nitrate
23. Einecs 246-051-4
24. Unii-5as8p3n30x
25. R-15,454
26. Adestan-g (tn)
27. 1-(2,4-dichloro-beta-(2,6-dichlorobenzyloxy)phenethyl)imidazole Nitrate
28. 1-(2-((2,6-dichlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)imidazole Nitrate
29. 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)-, Mononitrate
30. Schembl364401
31. Isoconazole Nitrate (travogen)
32. Isoconazole Nitrate [mi]
33. Dtxsid60946995
34. Hms3656a14
35. Hy-b1444
36. Isoconazole Nitrate [mart.]
37. Einecs 254-769-4
38. Isoconazole Nitrate [who-dd]
39. Mfcd01721647
40. S2534
41. Akos015895806
42. Ccg-269535
43. Cs-5151
44. Ks-1175
45. Isoconazole Nitrate [ep Impurity]
46. Isoconazole Nitrate [ep Monograph]
47. Ft-0654776
48. I0834
49. Sw196721-3
50. D01480
51. A817123
52. R 15454
53. J-015379
54. Q27261756
55. 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]-imidazole Mononitrate
56. 1-[2-(2,6-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Nitrate
| Molecular Weight | 479.1 g/mol |
|---|---|
| Molecular Formula | C18H15Cl4N3O4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 478.978717 g/mol |
| Monoisotopic Mass | 476.981667 g/mol |
| Topological Polar Surface Area | 93.1 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 431 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
68
PharmaCompass offers a list of Isoconazole Nitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Isoconazole Nitrate manufacturer or Isoconazole Nitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Isoconazole Nitrate manufacturer or Isoconazole Nitrate supplier.
PharmaCompass also assists you with knowing the Isoconazole Nitrate API Price utilized in the formulation of products. Isoconazole Nitrate API Price is not always fixed or binding as the Isoconazole Nitrate Price is obtained through a variety of data sources. The Isoconazole Nitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Adestan G 100; Fazol; Gyno-Travogen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Adestan G 100; Fazol; Gyno-Travogen, including repackagers and relabelers. The FDA regulates Adestan G 100; Fazol; Gyno-Travogen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Adestan G 100; Fazol; Gyno-Travogen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Adestan G 100; Fazol; Gyno-Travogen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Adestan G 100; Fazol; Gyno-Travogen supplier is an individual or a company that provides Adestan G 100; Fazol; Gyno-Travogen active pharmaceutical ingredient (API) or Adestan G 100; Fazol; Gyno-Travogen finished formulations upon request. The Adestan G 100; Fazol; Gyno-Travogen suppliers may include Adestan G 100; Fazol; Gyno-Travogen API manufacturers, exporters, distributors and traders.
click here to find a list of Adestan G 100; Fazol; Gyno-Travogen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Adestan G 100; Fazol; Gyno-Travogen Drug Master File in Japan (Adestan G 100; Fazol; Gyno-Travogen JDMF) empowers Adestan G 100; Fazol; Gyno-Travogen API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Adestan G 100; Fazol; Gyno-Travogen JDMF during the approval evaluation for pharmaceutical products. At the time of Adestan G 100; Fazol; Gyno-Travogen JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Adestan G 100; Fazol; Gyno-Travogen suppliers with JDMF on PharmaCompass.
A Adestan G 100; Fazol; Gyno-Travogen CEP of the European Pharmacopoeia monograph is often referred to as a Adestan G 100; Fazol; Gyno-Travogen Certificate of Suitability (COS). The purpose of a Adestan G 100; Fazol; Gyno-Travogen CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Adestan G 100; Fazol; Gyno-Travogen EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Adestan G 100; Fazol; Gyno-Travogen to their clients by showing that a Adestan G 100; Fazol; Gyno-Travogen CEP has been issued for it. The manufacturer submits a Adestan G 100; Fazol; Gyno-Travogen CEP (COS) as part of the market authorization procedure, and it takes on the role of a Adestan G 100; Fazol; Gyno-Travogen CEP holder for the record. Additionally, the data presented in the Adestan G 100; Fazol; Gyno-Travogen CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Adestan G 100; Fazol; Gyno-Travogen DMF.
A Adestan G 100; Fazol; Gyno-Travogen CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Adestan G 100; Fazol; Gyno-Travogen CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Adestan G 100; Fazol; Gyno-Travogen suppliers with CEP (COS) on PharmaCompass.
A Adestan G 100; Fazol; Gyno-Travogen written confirmation (Adestan G 100; Fazol; Gyno-Travogen WC) is an official document issued by a regulatory agency to a Adestan G 100; Fazol; Gyno-Travogen manufacturer, verifying that the manufacturing facility of a Adestan G 100; Fazol; Gyno-Travogen active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Adestan G 100; Fazol; Gyno-Travogen APIs or Adestan G 100; Fazol; Gyno-Travogen finished pharmaceutical products to another nation, regulatory agencies frequently require a Adestan G 100; Fazol; Gyno-Travogen WC (written confirmation) as part of the regulatory process.
click here to find a list of Adestan G 100; Fazol; Gyno-Travogen suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Adestan G 100; Fazol; Gyno-Travogen as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Adestan G 100; Fazol; Gyno-Travogen API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Adestan G 100; Fazol; Gyno-Travogen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Adestan G 100; Fazol; Gyno-Travogen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Adestan G 100; Fazol; Gyno-Travogen NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Adestan G 100; Fazol; Gyno-Travogen suppliers with NDC on PharmaCompass.
Adestan G 100; Fazol; Gyno-Travogen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Adestan G 100; Fazol; Gyno-Travogen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Adestan G 100; Fazol; Gyno-Travogen GMP manufacturer or Adestan G 100; Fazol; Gyno-Travogen GMP API supplier for your needs.
A Adestan G 100; Fazol; Gyno-Travogen CoA (Certificate of Analysis) is a formal document that attests to Adestan G 100; Fazol; Gyno-Travogen's compliance with Adestan G 100; Fazol; Gyno-Travogen specifications and serves as a tool for batch-level quality control.
Adestan G 100; Fazol; Gyno-Travogen CoA mostly includes findings from lab analyses of a specific batch. For each Adestan G 100; Fazol; Gyno-Travogen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Adestan G 100; Fazol; Gyno-Travogen may be tested according to a variety of international standards, such as European Pharmacopoeia (Adestan G 100; Fazol; Gyno-Travogen EP), Adestan G 100; Fazol; Gyno-Travogen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Adestan G 100; Fazol; Gyno-Travogen USP).
